Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT5DK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,420
Award facts
- Contract value 100% obligated
- $17,419.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,419.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 mL on January 6, 2026, with completion expected by January 7, 2026. This non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. The underlying IDC serves as a comprehensive global pharmaceutical supply vehicle enabling delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard.
Cosentyx is a biologic medication used to treat various inflammatory and autoimmune conditions, including psoriasis, psoriatic arthritis, and ankylosing spondylitis. The award reflects the continued reliance on AmerisourceBergen's pharmaceutical distribution capabilities to support military medical readiness and healthcare operations. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen has demonstrated consistent competitiveness in open federal procurement across multiple therapeutic domains and maintains a robust federal contract portfolio with various defense and civilian agencies.
Quick answers
Who was awarded contract SPE2DR26FT5DK?
SPE2DR26FT5DK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FT5DK worth?
The government has obligated $17,420 on SPE2DR26FT5DK.
Is contract SPE2DR26FT5DK an order under another contract?
Yes. SPE2DR26FT5DK is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5DK competed?
The extent of competition for SPE2DR26FT5DK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award